sec filing
FA
NASDAQ · FATE
Fate Therapeutics, Inc.
Healthcare · Biotechnology
$2.06
Up+$0.02 (+0.97%)
Updated Oct 27, 2026, 2:51 PM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 128M
- P/E ratio
- -0.85
- Dividend yield
- 0.00%
- 52-week range
- $0.95 – $3.23
- Volume
- 1.46M
- Avg. volume
- 2.11M
Price performance · FATE
FATE price history
1M range · 0 trading sessions · Daily adjusted prices
FATE does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest FATE news
The latest Smart Investors Daily articles mentioning FATE.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…